These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 11049974)

  • 1. Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin.
    Flinn IW; Kopecky KJ; Foucar MK; Head D; Bennett JM; Hutchison R; Corbett W; Cassileth P; Habermann T; Golomb H; Rai K; Eisenhauer E; Appelbaum F; Cheson B; Grever MR
    Blood; 2000 Nov; 96(9):2981-6. PubMed ID: 11049974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients.
    Maloisel F; Benboubker L; Gardembas M; Coiffier B; Divine M; Sebban C; Blanc M; Abgrall JF; Lederlin P; Harousseau JL; Blaise AM; Grosbois B; Morice P; Ghandour C; Castaigne S
    Leukemia; 2003 Jan; 17(1):45-51. PubMed ID: 12529659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: an intergroup study.
    Grever M; Kopecky K; Foucar MK; Head D; Bennett JM; Hutchison RE; Corbett WE; Cassileth PA; Habermann T; Golomb H
    J Clin Oncol; 1995 Apr; 13(4):974-82. PubMed ID: 7707126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome following treatment of hairy cell leukemia with pentostatin (Nipent): a National Cancer Institute of Canada study.
    Johnston JB; Eisenhauer E; Wainman N; Corbett WE; Zaentz SD; Daeninck PJ
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):32-6. PubMed ID: 10877049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response duration and recovery of CD4+ lymphocytes following deoxycoformycin in interferon-alpha-resistant hairy cell leukemia: 7-year follow-up.
    Seymour JF; Talpaz M; Kurzrock R
    Leukemia; 1997 Jan; 11(1):42-7. PubMed ID: 9001417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long term outcome of patients with hairy cell leukemia treated with pentostatin.
    Ribeiro P; Bouaffia F; Peaud PY; Blanc M; Salles B; Salles G; Coiffier B
    Cancer; 1999 Jan; 85(1):65-71. PubMed ID: 9921975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentostatin treatment for hairy cell leukemia patients who failed initial therapy with recombinant alpha-interferon: a report of CALGB study 8515.
    Golomb HM; Dodge R; Mick R; Budman D; Hutchison R; Horning SJ; Schiffer CA
    Leukemia; 1994 Dec; 8(12):2037-40. PubMed ID: 7807991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of interferon-alpha administration after 2-deoxycoformycin in the treatment of hairy cell leukemia patients.
    Marotta G; Frassoldati A; Zinzani P; Annino L; Brugiatelli M; Ambrosetti A; Lenoci M; Federico M; Foa R; Lauria F;
    Eur J Haematol; 2006 Aug; 77(2):109-13. PubMed ID: 16856905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentostatin induces durable remissions in hairy cell leukemia.
    Cassileth PA; Cheuvart B; Spiers AS; Harrington DP; Cummings FJ; Neiman RS; Bennett JM; O'Connell MJ
    J Clin Oncol; 1991 Feb; 9(2):243-6. PubMed ID: 1988572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentostatin in the treatment of hairy-cell leukemia.
    Grever MR; Doan CA; Kraut EH
    Best Pract Res Clin Haematol; 2003 Mar; 16(1):91-9. PubMed ID: 12670468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of essential thrombocythemia in a patient treated with interferon alfa and pentostatin for hairy cell leukemia.
    Lichtman SM; Wasil T; Ahmad M; Brody J
    Leuk Lymphoma; 1998 Jan; 28(3-4):423-7. PubMed ID: 9517515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of patients with hairy cell leukaemia after treatment with pentostatin or cladribine.
    Dearden CE; Matutes E; Hilditch BL; Swansbury GJ; Catovsky D
    Br J Haematol; 1999 Aug; 106(2):515-9. PubMed ID: 10460614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five years follow-up after 2-chloro deoxyadenosine treatment in thirty patients with hairy cell leukemia: evaluation of minimal residual disease and CD4+ lymphocytopenia after treatment.
    Bastie JN; Cazals-Hatem D; Daniel MT; D'Agay MF; Rabian C; Glaisner S; Noel-Walter MP; Dabout D; Flandrin G; Dombret H; Poisson D; Degos L; Castaigne S
    Leuk Lymphoma; 1999 Nov; 35(5-6):555-65. PubMed ID: 10609793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pentostatin (Nipent) in T-cell malignancies. Leukemia Cooperative Group and the European Organization for Research and Treatment of Cancer.
    Ho AD; Suciu S; Stryckmans P; De Cataldo F; Willemze R; Thaler J; Peetermans M; Döhner H; Solbu G; Dardenne M; Zittoun R
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):52-7. PubMed ID: 10877053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hairy cell leukemia treated initially with purine analogs: a retrospective study of 107 patients from the Spanish Cooperative Group on Chronic Lymphocytic Leukemia (GELLC).
    López Rubio M; Da Silva C; Loscertales J; Seri C; Baltasar P; Colado E; Pérez Fernández I; Osma M; Gomis F; González M; Jarque I; Vargas M; Monzó E; Monteagudo D; Orts MI; Pardal E; Carbonell F; Perez Calvo C; Garcia-Marco JA
    Leuk Lymphoma; 2014 May; 55(5):1007-12. PubMed ID: 23885799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis.
    Else M; Dearden CE; Matutes E; Garcia-Talavera J; Rohatiner AZ; Johnson SA; O'Connor NT; Haynes A; Osuji N; Forconi F; Lauria F; Catovsky D
    Br J Haematol; 2009 Jun; 145(6):733-40. PubMed ID: 19344416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended follow-up of patients with hairy cell leukemia after treatment with cladribine.
    Goodman GR; Burian C; Koziol JA; Saven A
    J Clin Oncol; 2003 Mar; 21(5):891-6. PubMed ID: 12610190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trials of pentostatin (Nipent) in hairy cell leukemia.
    Kraut EH
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):27-31. PubMed ID: 10877048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical overview of pentostatin (Nipent) use in lymphoid malignancies.
    Dearden CE; Matutes E; Catovsky D
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):22-6. PubMed ID: 10877047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long remissions in hairy cell leukemia with purine analogs: a report of 219 patients with a median follow-up of 12.5 years.
    Else M; Ruchlemer R; Osuji N; Del Giudice I; Matutes E; Woodman A; Wotherspoon A; Swansbury J; Dearden C; Catovsky D
    Cancer; 2005 Dec; 104(11):2442-8. PubMed ID: 16245328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.